Skip to main content
APHEXDA 62 mg/1.7mL injection, powder, lyophilized, for solution by Gamida Cell Inc.
APHEXDA, 62 mg/1.7mL, injection, powder, lyophilized, for solution Available on prescription only. Listed by Gamida Cell Inc..
Prescription only

APHEXDA

MOTIXAFORTIDE

Listed by Gamida Cell Inc.

Strength
62 mg/1.7mL
Form
Injection, Powder, Lyophilized, For Solution
Route
Subcutaneous

What it contains

  • Motixafortide Acetate 62 mg/1.7mL

FDA record

Dosage form Injection, Powder, Lyophilized, For Solution
Route Subcutaneous
Approval route NDA — original brand approval
NDC code 73441-062
FDA application NDA217159
RxNorm concept 2664901
Package sizes listed 1
Marketed since June 2025

Other products containing Motixafortide

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Aphexda

Motixafortide

Strength
62 mg/1.7mL
Form
Injection, Powder, Lyophilized, For Solution
Rx only

BioLineRx USA Inc

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.